NASDAQ:KRYS - Krystal Biotech, Inc.
$51.16
 $1.75
+3.54%
12:10PM EDT
2019-07-22
Krystal Biotech, Inc., incorporated on March 31, 2017, gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Companys products include KB103 and KB104. The Companys lead product candidate, KB103, is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. DEB affects the skin and mucosal tissues, and is caused by one or more mutations in a gene called COL7A1, which is responsible for the formation of protein type VII collagen, or COL7, that forms anchoring fibrils that bind the dermis, or inner layer of the skin, to the epidermis, or outer layer of the skin. KB103 is a replication-defective, non-integrating viralKrystal Biotech, Inc., incorporated on March 31, 2017, gene therapy company. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KRYS     avg for
industry   		  avg for
sector  
42 stocks weight:  99. 89   217. 37   399. 45  
42 stocks rank:  1. 75 K 1. 27 K 716. 99  
# analyst opinions:  5. 00   13. 21   13. 71  
mean recommendation:  1. 60   2. 10   2. 04  
quick ratio:  32. 89   5. 49   1. 88  
current ratio:  33. 28   5. 87   2. 36  
target price low:  $ 56. 00   $ 83. 44   $ 114. 90  
target price avg:  $ 66. 40   $ 106. 20   $ 137. 90  
target price high:  $ 75. 00   $ 132. 30   $ 158. 97  
1-yr high:  $ 49. 41   $ 111. 86   $ 142. 57  
last close:  $ 49. 41   $ 86. 79   $ 125. 44  
50-day avg:  $ 36. 56   $ 86. 68   $ 122. 63  
200-day avg:  $ 27. 20   $ 89. 22   $ 121. 38  
1-yr low:  $ 15. 03   $ 69. 78   $ 100. 51  
volume:  210. 30 K 2. 62 M 3. 43 M
50-day avg volume:  218. 02 K 3. 20 M 4. 16 M
200-day avg volume:  114. 79 K 2. 99 M 4. 75 M
1-day return:  2. 19 % -1. 30 % -0. 99 %
this week return:  5. 13 % 0. 45 % -0. 20 %
12-wk return:  49. 73 % 0. 94 % 4. 84 %
52-wk return:  161. 92 % -1. 30 % 10. 55 %
enterprise value (EV):  $ 610. 42 M $ 45. 10 B $ 122. 38 B
market cap:  $ 837. 18 M $ 38. 96 B $ 108. 40 B
EBITDA:  $ -14. 08 M $ 4. 20 B $ 8. 19 B
enterprise multiple (EV/EBITDA):  -43. 36   5. 38   11. 93  
total debt:  $ 3. 39 M $ 10. 90 B $ 17. 48 B
debt/equity:  3. 10   57. 18   120. 05  
net income (common):  $ -12. 85 M $ 2. 07 B $ 4. 05 B
shares outstanding:  14. 44 M 538. 09 M 1. 24 B
shares:  9. 20 M 548. 00 M 1. 22 B
shares short:  624. 34 K 10. 98 M 11. 87 M
shares short prior month:  576. 67 K 9. 32 M 12. 05 M
short ratio:  1. 90   5. 60   3. 34  
short % of float:  6. 58 % 6. 48 % 2. 64 %
total cash/share:  $ 7. 38   $ 10. 98   $ 9. 19  
total cash:  $ 106. 63 M $ 5. 93 B $ 6. 10 B
free cash flow:  $ -9. 99 M $ 2. 92 B $ 4. 55 B
operating cash flow:  $ -10. 29 M $ 3. 80 B $ 5. 78 B
book value:  $ 7. 58   $ 13. 35   $ 27. 45  
price/book:  6. 52   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %
1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %
1-yr EPS:  -1. 05   2. 10   4. 23  
forward EPS:  -1. 92   3. 45   7. 10  
P/E:  -47. 01   1. 90   32. 10  
forward P/E:  -25. 73   6. 46   15. 47  
PE/G:  41. 18   0. 70   -0. 54  
growth:  -1. 14 % 265. 63 % 79. 11 %
earnings high:  $ -0. 29   $ 0. 89   $ 1. 68  
earnings avg:  $ -0. 32   $ 0. 70   $ 1. 57  
earnings low:  $ -0. 35   $ 0. 46   $ 1. 46  
revenue high:  $ -0. 00   $ 2. 57 B $ 11. 07 B
revenue avg:  $ -0. 00   $ 2. 51 B $ 10. 91 B
revenue low:  $ -0. 00   $ 2. 45 B $ 10. 73 B
return on assets:  -10. 95 % -2. 34 % 5. 28 %
return on equity:  -16. 38 % -90. 08 % 133. 53 %
beta (1yr vs S&P500):  1. 07   1. 27   0. 91  
sharpe (1yr):  1. 60   0. 16   0. 77  
held % insiders:  32. 99 % 6. 06 % 3. 29 %
held % institutions:  43. 14 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : KRYS
.    145.441 =       145.441 :: --> INITIAL WEIGHT <--
.    - 1.051 =        144.39 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.905 =       419.448 :: P/E factor
.     x 0.78 =       327.197 :: PE/G factor
.      x 1.6 =        523.67 :: beta factor
.    x 1.601 =       838.446 :: sharpe factor
.    x 5.045 =      4230.167 :: current ratio factor
.    x 1.016 =      4295.979 :: quick ratio factor
.    x 1.235 =      5307.431 :: short ratio factor
.    x 1.078 =      5721.625 :: price-to-book factor
.    x 1.027 =      5874.671 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     12458.961 :: sector+industry 1-year gains factor
.    x 1.009 =     12576.425 :: industry 12-weeks return factor
.    x 1.308 =     16448.562 :: industry 2-weeks return factor
.    x 2.696 =     44338.432 :: company one-year gains+dividend factor
.    x 3.716 =    164775.767 :: company 13 weeks' performance factor
.    x 2.554 =    420777.592 :: 5-day avg > 200-day avg
.    x 2.354 =    990329.094 :: 5-day avg > 50-day avg
.    x 1.344 =   1330760.176 :: 50-day avg > 200-day avg
.    / 2.066 =    644176.386 :: overall "drift" factor
.    x 0.286 =    184102.207 :: largest single-day jump factor
.        x 1 =    184102.207 :: volatility factor
.        x 1 =    184102.207 :: 42-day volatility factor
.     x 1.59 =    292747.573 :: notable returns + performance factor
.    x 1.387 =    406029.433 :: performance vs s&p500 factor
.    x 1.169 =    474593.362 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.812 =    385606.262 :: forward EPS factor
.    x 0.932 =    359333.195 :: forward P/E factor
.    x 1.185 =    425706.528 :: industry recommendation factor
.    x 2.622 =   1116370.412 :: company recommendation factor
.    x 1.003 =   1119457.605 :: factor historical industry gain for week 29
.    x 1.453 =   1626700.424 :: target low factor
.    x 1.195 =   1944662.694 :: target mean factor
.     x 1.03 =   2003441.571 :: target high factor
.   x 10.168 =  20371836.562 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        67.183 :: reduced for readability
.   + 32.707 =         99.89 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      99.89 :: FINAL WEIGHT for NASDAQ:KRYS

 

News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org